At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Nov 4, 2026 at 16:30 ET
STERIS reported fiscal Q2 2027 adjusted EPS of $2.94, beating the $2.68 consensus by 9.7%, and revenue of $1.6B (+9% YoY) vs. $1.56B consensus. The company raised its full-year adjusted EPS guidance to $11.35-$11.55 from $11.10-$11.30, citing solid underlying demand and ~$0.18 benefit from tariff refunds. Life Sciences revenue grew 18% and guidance for that segment was raised, while Healthcare and AST met expectations.
- Adjusted EPS $2.94 vs. consensus $2.68 (beat by 9.7%)
- Revenue $1.6B vs. consensus $1.56B (beat by 2.6%)
- Revenue +9% YoY; constant currency organic revenue +8%
- FY2027 adjusted EPS guidance raised to $11.35-$11.55 from $11.10-$11.30
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access